2007
DOI: 10.1183/09031936.00110207
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…When mice were treated with 6-mercaptopurine, significant alterations were observed in the expression of genes associated with abnormal lipid metabolism, inflammatory responses, oxidative stress, ATP depletion, and cell death [41]. Although several cases of azathioprine induced ILD are known, so far, in only one case TPMT deficiency has been associated with pulmonary toxicity [14,42].…”
Section: Thiopurine S-methyltransferasementioning
confidence: 99%
See 1 more Smart Citation
“…When mice were treated with 6-mercaptopurine, significant alterations were observed in the expression of genes associated with abnormal lipid metabolism, inflammatory responses, oxidative stress, ATP depletion, and cell death [41]. Although several cases of azathioprine induced ILD are known, so far, in only one case TPMT deficiency has been associated with pulmonary toxicity [14,42].…”
Section: Thiopurine S-methyltransferasementioning
confidence: 99%
“…In case of an azathioprine indication, also used as treatment for certain ILDs, testing TPMT variants involved in azathioprine metabolism is advised before starting treatment [42][43][44]. In the Unites States of America, drug labels for azathioprine now include information on TPMT polymorphisms and recommend determining patients' phenotype or genotype prior to drug treatment [45].…”
Section: Thiopurine S-methyltransferasementioning
confidence: 99%
“…Few data exist regarding myostatin in COPD, but a recent crosssectional study showed a three-fold increase in vastus lateralis myostatin mRNA transcripts in COPD patients with significant quadriceps weakness compared to healthy controls [3]. However, the relationship between quadriceps myostatin expression and functional characteristics of the muscle is not known.…”
Section: To the Editorsmentioning
confidence: 97%
“…Aberrant enzyme activity of either TPMT or ITPase gives rise to a broad spectrum of adverse drug reactions (ADR) associated with thiopurines, ranging from therapeutic failure to life-threatening leukopenia [3,4].…”
Section: To the Editorsmentioning
confidence: 99%
“…The promise of pharmacogenetics lies in its potential to identify the right drug and dose for each patient. Even though individual differences in drug response can result from the effects of age, sex, disease or drug interactions, genetic factors also influence both the efficacy of a drug and the likelihood of an adverse reaction occurring [1][2][3]. There is an increasing number of examples in which pharmacogenetic studies have indicated that a genetic test prior to treatment may be useful either for setting the individual dose or making a decision to use a particular drug [4][5][6].…”
mentioning
confidence: 99%